Methyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(trifluoromethyl)benzoate, 10g

6-Methyl-4-(trifluoromethyl)nicotinonitrile, 95.0%, 1g

2-(hydroxymethyl)-4(3H)-quinazolinone hydrochloride, 95.0%, 250mg

Benzaldehydeoxime, 90.0%, 500g

2-[2-(trifluoromethyl)-1,3-thiazol-4-yl]acetic acid, 96%, 1g

N-(2-(4,4-Dimethyl-4,5-dihydrooxazol-2-yl)phenyl)-6-methylpicolinamide, 98%, 1g

Filtration unit with SFCA membrane Pore size 0.45 μm, 250 ml, 250 ml, 50 mm, 12 Piece(s)

6,7,8,9-Tetrahydro-5H-benzocyclohepten-5-one>97.0%(GC)5g

1-(4-Chloro-3-fluorophenyl)ethanamine hydrochloride, 97%, 5g

CYCLOPROPYL(PYRIDIN-2-YL)METHANAMINE HCL, 98.0%, 1g

(S)-N-(Pyrrolidin-3-yl)acetamide hydrochloride, 95.0%, 10g

7-amino-4-methyl-3,4-dihydro-1,4-benzoxazepin-5(2H)-one, 95.0%, 250mg

(1,4-Dimethylpiperazin-2-yl)methanol, 97.0%, 10g